Non-Hodgkin lymphomas: Current aspects

被引:2
|
作者
Rozman, C [1 ]
机构
[1] Univ Barcelona, Barcelona, Spain
关键词
non-Hodgkin lymphomas; nervous system; ophthalmology; otorhinolaryngology;
D O I
10.33588/rn.3112.2000088
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. We wish to briefly review current knowledge of non-Hodgkin lymphomas ((NHL) with special emphasis on aspects of interest in ophthalmology, otorhinolaryngology and neurology. Development. We analyze the historical evolution of the classification of the NHL and refer to that recently devised by the World Health Organization. Amongst the numerous conditions forming part of this group of disorders we refer to the main data (clinical, immunophenotype, cytogenetics and of molecular biology) relative to the five most important types: 1. Follicular lymphoma; 2. Diffuse large cell lymphoma; 3. 'Mantle' cell lymphoma; 4. MALT lymphoma (mucosa associated lymphoid tissue), and 5 Peripheral T lymphoma. Then we describe the types and clinical forms of NHL in ophthalmology, otorhinolaryngology and neurology. Finally we consider the recent advances in prognosis (international index, biological markers) and treatment (new types of polychemotherapy, eradication of Helicobacter pylori, transplant of hemopoietic progenitors, monoclonal antibodies and anti-sense treatment of these conditions. Conclusions. The NHL form a group of conditions in which the annual increase in recent years has been over 4%. With considerable frequency these rumors are found from the beginning or during their course in otorhinological and ophthalmic tissues, or in the nervous system; in the latter case, apart from direct tumour expression they may also cause paraneoplastic manifestations.
引用
收藏
页码:1275 / 1280
页数:6
相关论文
共 50 条
  • [1] Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
    Pytlik, Robert
    Polgarova, Kamila
    Karolova, Jana
    Klener, Pavel
    VACCINES, 2020, 8 (04) : 1 - 42
  • [2] Molecular pathology of non-Hodgkin lymphomas
    Shahidi-Asl, M
    Krause, JR
    JOURNAL OF CLINICAL LIGAND ASSAY, 2001, 24 (02): : 65 - 75
  • [3] SIGNIFICANCE OF ANEUPLOIDY IN NON-HODGKIN LYMPHOMAS
    VUCKOVIC, J
    FORENPOHER, G
    MARUSIC, M
    UZAREVIC, B
    SABIONCELLO, A
    STULA, N
    DUBRAVCIC, M
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1995, 9 (06) : 343 - 346
  • [4] Drug Resistance in Non-Hodgkin Lymphomas
    Klener, Pavel
    Klanova, Magdalena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [5] Bone Marrow Involvement by Hodgkin and Non-Hodgkin Lymphomas
    Zhang, Qian-Yun
    Foucar, Kathryn
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (04) : 873 - +
  • [6] Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas
    L Loni
    M Del Tacca
    R Danesi
    British Journal of Cancer, 2001, 85 : 1425 - 1431
  • [7] DIFFERENTIAL-DIAGNOSIS OF NON-HODGKIN LYMPHOMAS
    OSTER, W
    ARZTLICHE LABORATORIUM, 1991, 37 (04): : 95 - 102
  • [8] Pesticides exposure and subgroups of non-hodgkin lymphomas
    Aras, M.
    Jeanne, A.
    Eisinger, F.
    Bellagamba, G.
    Garciaz, S.
    Bouabdallah, R.
    Lehucher-Michel, M-P
    ONCOLOGIE, 2014, 16 (9-10) : 465 - 472
  • [9] Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas
    Loni, L
    Del Tacca, M
    Danesi, R
    BRITISH JOURNAL OF CANCER, 2001, 85 (10) : 1425 - 1431
  • [10] TREATMENT AND PROGNOSIS OF ORBITAL NON-HODGKIN LYMPHOMAS
    PLATANIAS, LC
    PUTTERMAN, AM
    VIJAYAKUMAR, S
    RECANT, W
    WEICHSELBAUM, RR
    BITRAN, JD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (01): : 79 - 83